Victory Capital Management’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-477
Closed -$10K 3476
2020
Q1
$10K Buy
+477
New +$13K ﹤0.01% 3321
2019
Q4
Sell
-238
Closed -$12K 3460
2019
Q3
$12K Buy
+238
New +$10.5K ﹤0.01% 3202
2017
Q3
Sell
-69
Closed -$16K 1888
2017
Q2
$16K Buy
69
+1
+1% +$261 ﹤0.01% 1780
2017
Q1
$23K Hold
68
﹤0.01% 1766
2016
Q4
$14K Buy
68
+4
+6% +$954 ﹤0.01% 1777
2016
Q3
$22K Buy
64
+4
+7% +$1.06K ﹤0.01% 1745
2016
Q2
$12K Buy
60
+9
+18% +$1.98K ﹤0.01% 1618
2016
Q1
$14K Buy
51
+4
+9% +$1.07K ﹤0.01% 1634
2015
Q4
$20K Buy
47
+3
+7% +$1.34K ﹤0.01% 1647
2015
Q3
$20K Buy
44
+3
+7% +$1.33K ﹤0.01% 1584
2015
Q2
$20K Buy
+41
New +$18.8K ﹤0.01% 1594

Other funds holding ACGN

Victory Capital Management's ACGN Position: Q2 2020 in Review

Victory Capital Management sold out of Aceragen Inc (ACGN) in Q2 2020, closing a stake of 477 shares — an estimated $10K sold.

Victory Capital Management first reported a position in ACGN in Q2 2015 and held it in 11 quarters. The position peaked at $23K in Q1 2017. 44 funds tracked by Wall St. Rank hold ACGN as of Q2 2020.

  • Victory Capital Management reported no remaining Aceragen Inc position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 477 Aceragen Inc shares in Q2 2020, an estimated $10K.
  • Victory Capital Management first reported a position in Aceragen Inc in Q2 2015 and held it in 11 quarters.
  • Victory Capital Management's Aceragen Inc position peaked at $23K in Q1 2017.
  • 44 funds tracked by Wall St. Rank held Aceragen Inc as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.